Spruce Biosciences Inc
(SPRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,320 | -16,108 | -14,041 | -53,036 | -29,477 |
| Depreciation Amortization | 16 | 13 | 6 | 46 | 37 |
| Accounts payable and accrued liabilities | 91 | -488 | 584 | -2,037 | -1,533 |
| Other Working Capital | -3,131 | -5,439 | 857 | -8,571 | -10,419 |
| Other Operating Activity | 473 | 467 | -133 | 7,634 | 6,105 |
| Operating Cash Flow | $-26,871 | $-21,555 | $-12,727 | $-55,964 | $-35,287 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,216 | -811 | -405 | -1,622 | -1,216 |
| Common Stock Issued | 3 | N/A | N/A | 246 | 232 |
| Other Financing Activity | 0 | 0 | -6 | -246 | -13 |
| Financing Cash Flow | $-1,213 | $-811 | $-411 | $-1,622 | $-997 |
| Beginning Cash Position | 38,788 | 38,788 | 38,788 | 96,374 | 96,374 |
| End Cash Position | 10,704 | 16,422 | 25,650 | 38,788 | 60,090 |
| Net Cash Flow | $-28,084 | $-22,366 | $-13,138 | $-57,586 | $-36,284 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,871 | -21,555 | -12,727 | -55,964 | -35,287 |
| Free Cash Flow | -26,871 | -21,555 | -12,727 | -55,964 | -35,287 |